Skip to main content
. 2011 Feb 4;84(Suppl 2):28–34. doi: 10.4269/ajtmh.2011.09-0499

Table 4.

Characteristics of batches available in two human challenges. Percentages and means were calculated from 70 mosquitoes per batch

Mosquito batches Infectious screening % Infected mosquitoes Mean oocyst/mosquito % Infected mosquitoes Mean spz/mosquito
1 Neg 85.0 21.1 97.3 824
2 Neg 85.5 22.5 94.7 20
3 Neg 71.0 18.1 86.5 1,043
4 Neg 88.1 18.2 84.2 2,034
5 Neg 72.0 38.9 78.9 3,773
6 Neg 69.7 45.5 68.4 883
7 Neg 76.0 15.4 63.2 4,582
8 Neg 69.7 5.4 55.3 407
9 Neg 57.9 6.4 15.8 20
10 Neg 52.6 3.6 47.4 55
11 Neg 53.9 4.6 44.7 407
12 Neg 38.5 2.5 47.4 48
13 Neg 46.1 2.7 21.1 146
14 Neg 23.7 1.2 31.6 429
15 Neg 62.9 2.6 ND ND
16 Neg 74.3 7.2 ND ND
17 Neg 18.9 0.2 ND ND
18 Neg 13.3 0.4 ND ND
19 Neg 4.0 0.2 ND ND
20 Neg 0.0 0.0 ND ND
21 Neg 6.6 0.4 ND ND
22 Neg 1.3 2.9 ND ND
23 Hepatitis B 78.7 20.9 ND ND
24 Hepatitis B 84.0 9.4 ND ND
25 Hepatitis B 90.0 43.2 ND ND
26 Hepatitis B 10.5 0.5 ND ND
27 Hepatitis B 59.2 3.9 ND ND
28 Hepatitis B 48.7 2.9 ND ND
29 Hepatitis B, C 5.3 3.9 ND ND
30 Syphilis 6.7 0.1 ND ND
31 Syphilis 78.9 22.4 ND ND
32 Syphilis + HTLV 80.3 32.1 ND ND
33 HTLV 1-2 89.3 26.2 ND ND